Wang Qunbin, aged 50, is an Executive Director and Co-Chairman of the Company.

Mr. Wang is the founder of the Company and its subsidiaries (the “Group”) and has been a director of various companies within the Group since 1994. Mr. Wang was a director of Shanghai Yuyuan Tourist Mart (Group) Co., Ltd. (listed on the Shanghai Stock Exchange with stock code 600655, (“Yuyuan”)) and Henan Lingrui Pharmaceutical Co., Ltd. (listed on the Shanghai Stock Exchange with stock code 600285) and a non-executive director of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (listed on the Hong Kong Stock Exchange with stock code 02196 and the Shanghai Stock Exchange with stock code 600196, (“Fosun Pharma”)) and Sinopharm Group Co., Ltd. (listed on the Hong Kong Stock Exchange with stock code 01099, (“Sinopharm”)). Mr. Wang was awarded “Asia Pacific Outstanding Entrepreneur Awards” by Enterprise Asia and “Best Asian Corporate Director” at the Asian Excellence Recognition Awards by Corporate Governance Asia, etc., and was named one of “China’s 50 Top-performing Corporate Leaders” by Harvard Business Review. Mr. Wang received a bachelor’s degree in genetic engineering from Fudan University in 1991.